Resources This book is available in Oxford Scholarship Online - view abstracts and keywords at book and chapter level.
Related Categories
|
Also Recommended
|
|
|
Developing Good Practice
Emile Tompa, Anthony J Culyer...
£39.99
|
|
|
|
|
Jan Abel Olsen
£34.99
|
|
|
|
|
|
John Brazier, Julie Ratcliffe...
£45.00
|
|
|
|
|
The Economics of New Health Technologies
Incentives, organization, and financing
Edited by Joan Costa-Font, Christophe Courbage, and Alistair McGuire
312 pages
|
31 black-and-white line drawings
|
234x156mm
978-0-19-955068-5
|
Paperback
|
14 May 2009
|
|
|
|
|
- Contains a general health economics perspective, relevant to those in both health economics and policy
- Looks at the whole process of innovation, making it an important resource for practitioners in the public and private sectors
- Broader than simple economic evaluation, the book considers the behavioural aspects, organization, incentives, adoption and diffusion of new health technologies
- Hugely topical for modern healthcare, relevant to issues such as nano-technology, cloning, and tissue engineering
- Contributions from international experts including economists, health policy analysts, clinicians, and social scientists
Technological change in healthcare has led to huge improvements in health services and the health status of populations. It is also pinpointed as the main driver of healthcare expenditure. Although offering remarkable benefits, changes in technology are not free and often entail significant financial, as well as physical or social risks. These need to be balanced out in the setting of government regulations, insurance contracts, and individuals' decisions to use and consume certain technologies. With this in mind, this book addresses the following important objectives: to provide a detailed
analysis of what technological change is; to identify drivers of innovation in several healthcare areas; to present existing mechanisms and processes for ensuring and valuing efficiency and development in the use of medical technologies; and to analyse the impact of advances in medical technology on health, healthcare expenditure, and health insurance.
Each of the seventeen chapters summarizes an important issue concerning the innovation debate and contributes to a better understanding of the role innovation has both at the macro level and at the delivery (meso) and micro level in the healthcare sector. The effectiveness of innovation in improving people's welfare depends on its diffusion and inception by the relevant agents in the health production process, and
this book recognizes the multi-faceted contribution of policy makers, regulators, managers, technicians, consumers and patients to this technology change.
This book offers the first truly global economic analysis of healthcare technologies, taking the subject beyond simply economic evaluation, and exploring the behavioural aspects, organization and incentives for new technology developments, and the adoption and diffusion of these technologies.Readership: The book will primarily appeal to health economists, policy makers, analysts and researchers, but is also of interest to those studying social science, management, innovation, or technology, and those working in the pharmaceutical
industry.
|
|
|
Edited by Joan Costa-Font, Senior Research Fellow and Lecturer, Health and Social Care Department, London School of Economics, UK, Christophe Courbage, Director of Research, The Geneva Association (International Association for the Study of Insurance Economics); Lecturer in Health Economics, Institute of Health Economics and Management, University of Lausanne, Switzerland, and Alistair McGuire, Professor of Health Economics and Health, Department of Social Policy, London School of Economics, UK Contributors:
Nick Bosanquet, Professor of Health Policy, Imperial College London, UK
Davide Consoli,
Manchester Institute of Innovation Research (MIoIR), Manchester Business School, Manchester, UK
Joan Costa-Font, LSE Health, and European Institute, London School of Economics and Political Science, London, UK
Roland Eisen , Department of Economics, University of Frankfurt, Germany
Lauri Feldman, Undergraduate student, Columbia College, Chicago,USA
Lilia Filipova, University of Augsburg, Germany
Manuel García-Goñi, Universidad Complutense de Madrid, Spain
Marin Gemmill, LSE Health, London School of Economics and Political Science, London, UK
Joshua Graff Zivin, Associate Professor, Department of Health Policy and Management, Columbia University, New York, USA
Yasemin Ilgin, University of Frankfurt,
Germany
Adam Isen, Business and Public Policy, The Wharton School, University of Pennsylvania, USA
Michael Hoy, Department of Economics, University of Guelph, Canada
Frank R. Lichtenberg, Columbia University and National Bureau of Economic Research, New York, USA
Alistair McGuire, LSE Health, London School of Economics and Political Science, UK
Andrew McMeekin, Manchester Institute of Innovation Research (MIoIR), Manchester Business School, Manchester, UK
J. Stan Metcalfe, Manchester Institute of Innovation Research (MIoIR), Manchester Business School, and Centre for Business Research, University of Cambridge, UK
Andrea Mina, Centre for Business Research, University of Cambridge, UK
Elias Mossialos, LSE
Health, London School of Economics, London, UK
Matthew Neidell, Assistant Professor, Department of Health Policy and Management, Columbia University, New York, USA
Adam Oliver, LSE Health, London School of Economics and Political Science, UK
Nicola Pangher, Director, ITALTBS SpA, Italy
Mark V. Pauly, Health Care Systems Department, The Wharton School, University of Pennsylvania, USA
Hristina Petkova, EGENIS, University of Exeter, UK
Ronnie Ramlogan, Manchester Institute of Innovation Research (MIoIR), Manchester Business School, UK
Joan Rovira, University of Barcelona, Spain
Caroline Rudisill, LSE Health, London School of Economics, UK
Victoria Serra-Sastre, LSE Health, London School of
Economics and Political Science, UK
Corinna Sorenson, LSE Health, London School of Economics and Political Science, UK
Paul Windrum, MMUBS, Manchester, UK
Peter Zweifel, University of Zurich, Switzerland
|
|
|
Part I. Introduction
1: Alistair McGuire & Victoria Serra: What do we know about the role of health care technology in driving healthcare expenditure growth?
Part II. Innovation, diffusion and technology change
2: Davide Consoli, Andrew McMeekin, J. Stan Metcalfe, Andrea Mina & Ronnie Ramlogan: The process of innovation: incentives, behaviour and organization
3: Nick Bosanquet: Technology - scientific force or power force?
4: Victoria Serra-Sastre & Alistair McGuire: Diffusion of health technologies: evidence from the pharmaceutical sector
Part III. Technological change and health insurance
5: Mark Pauly & Adam Isen: Insurance and new health technology
6: Peter Zweifel: Technological change and health insurance
7: Marin Gemmill, Victoria Serra & Joan Costa-Font: Health insurance and the uptake of new drugs in the United States
8: Lilia Filipova & Michael Hoy: Genetic advances and health insurance
Part IV. Innovation, social demand and valuation
9: Roland Eisen & Yasemin Ilgin: Ageing and pharmaceutical innovation
10: Manuel García-Goñi & Paul Windrum: New approaches to healthcare innovation: information for chronic patients
11: Nicola Pangher: The convergence of nano-, bio- and information technologies in healthcare
12: Joshua Graff Zivin, Matthew Neidell, & Lauri Feldman: Treatment uncertainty and irreversibility in medical care: implications for cost-effectiveness analysis
13: Adam Oliver & Corinna Sorenson: The limits and challenges to the economic evaluation of health technologies
Part V. Incentives, mechanisms and processes
14: Joan Rovira: Intellectual property rights and pharmaceuticals development
15: Frank R. Lichtenberg: Home, or nursing home? The effect of medical innovation on the demand for long-term care
16: Joan Costa-Font, Caroline Rudisill & Elias Mossialos: Demand for health information on the internet
17: Hristina Petkova: Institutional pathways for integrating genetic testing into mainstream healthcare
|
|
|
|
|
|
|
|
|
The specification in this catalogue, including without limitation price, format, extent, number of illustrations, and month of publication, was as accurate as possible at the time the catalogue was compiled. Occasionally, due to the nature of some contractual restrictions, we are unable to ship a specific product to a particular territory. Jacket images are provisional and liable to change before publication.
|
|
